<p>C57BL/6 mice were fed 0.2% cuprizone chow for five weeks and returned to a normal diet for a sixth week. A cohort of mice was sacrificed weekly throughout the disease course, brains were extracted, and CNS processed for flow cytometry (n = 5). Naïve mice were concurrently assayed at each time point for standardization (n = 3). (<b>A</b>) Cells were first gated by forward and side scatter then single cells were gated. Live cells were next gated, and hematopoietic cells excluded by gating on CD45<sup>-/low</sup> cells. (<b>B</b>) From the CNS resident cells, oligodendroglial populations were defined: A2B5<sup>+</sup>PDGFRα<sup>+</sup> early OPCs, PDGFRα<sup>+</sup>O4<sup>+</sup> intermediate OPCs, O4<sup>+</sup>O1<sup>+</sup> pre-myelinati...
Cuprizone administration in mice provides a reproducible model of demyelination and spontaneous remy...
Abstract Cuprizone is a copper-chelating agent that induces pathology similar to that within some mu...
Objectives: Multiple sclerosis (MS) is characterized by recurrent and progressive demyelination/remy...
Abstract Background Multiple sclerosis (MS) is a severe neurological disorder, characterized by demy...
<p>(A–B) Immunostaining of BrdU-Olig2 (A) and GFAP (B) of the midline corpus callosum of the infused...
<p>Mice were fed with 0.25% cuprizone for six weeks and the numbers of oligodendroglial lineage cell...
To understand why remyelination fails in diseases such as multiple sclerosis (MS), I studied the cel...
<p>SJL/J mice were immunized with PLP<sub>139–151</sub> and scored daily for clinical disease. A coh...
<p>(a) Representative images of JunB<sup>f/f</sup>/c-Jun<sup>f/f</sup> controls and JunB<sup>Δol</su...
Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease that affects the central n...
Multiple sclerosis is a widespread demyelinating disease where primary oligodendrocyte dysfunction r...
<p>(<b>A–B</b>) Representative light micrographs of sagittal sections of brain from control and cupr...
Cuprizone (CPZ) preferentially affects oligodendrocytes (OLG), resulting in demyelination. To invest...
To study microglial/macrophage infiltration, a cuprizone-induced model for demyelination in C57BL/6 ...
To understand mechanisms that may underlie the progression of a demyelinated lesion to a chronic sta...
Cuprizone administration in mice provides a reproducible model of demyelination and spontaneous remy...
Abstract Cuprizone is a copper-chelating agent that induces pathology similar to that within some mu...
Objectives: Multiple sclerosis (MS) is characterized by recurrent and progressive demyelination/remy...
Abstract Background Multiple sclerosis (MS) is a severe neurological disorder, characterized by demy...
<p>(A–B) Immunostaining of BrdU-Olig2 (A) and GFAP (B) of the midline corpus callosum of the infused...
<p>Mice were fed with 0.25% cuprizone for six weeks and the numbers of oligodendroglial lineage cell...
To understand why remyelination fails in diseases such as multiple sclerosis (MS), I studied the cel...
<p>SJL/J mice were immunized with PLP<sub>139–151</sub> and scored daily for clinical disease. A coh...
<p>(a) Representative images of JunB<sup>f/f</sup>/c-Jun<sup>f/f</sup> controls and JunB<sup>Δol</su...
Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease that affects the central n...
Multiple sclerosis is a widespread demyelinating disease where primary oligodendrocyte dysfunction r...
<p>(<b>A–B</b>) Representative light micrographs of sagittal sections of brain from control and cupr...
Cuprizone (CPZ) preferentially affects oligodendrocytes (OLG), resulting in demyelination. To invest...
To study microglial/macrophage infiltration, a cuprizone-induced model for demyelination in C57BL/6 ...
To understand mechanisms that may underlie the progression of a demyelinated lesion to a chronic sta...
Cuprizone administration in mice provides a reproducible model of demyelination and spontaneous remy...
Abstract Cuprizone is a copper-chelating agent that induces pathology similar to that within some mu...
Objectives: Multiple sclerosis (MS) is characterized by recurrent and progressive demyelination/remy...